Forearm Bone Density In Users Of Depo-provera As A Contraceptive Method.

dc.creatorBahamondes, L
dc.creatorPerrotti, M
dc.creatorCastro, S
dc.creatorFaúndes, D
dc.creatorPetta, C
dc.creatorBedone, A
dc.date1999-May
dc.date2015-11-27T12:19:35Z
dc.date2015-11-27T12:19:35Z
dc.date.accessioned2018-03-29T00:53:28Z
dc.date.available2018-03-29T00:53:28Z
dc.identifierFertility And Sterility. v. 71, n. 5, p. 849-52, 1999-May.
dc.identifier0015-0282
dc.identifier
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/10231044
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/194354
dc.identifier10231044
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1294587
dc.descriptionTo determine the influence of depot medroxyprogesterone acetate (MPA) on bone mineral density when used as a contraceptive method. Cross-sectional study. Academic tertiary-care hospital. Fifty premenopausal women who had used depot MPA as a contraceptive method for > or =1 year and 50 women who had never used hormonal contraceptive methods. Bone mineral density was evaluated at the midshaft and at the distal radius of the nondominant forearm using single x-ray absorptiometry. Bone mineral density. Bone mineral density at the midshaft of the forearm was lower in depot MPA users than in women who had never used hormonal contraceptive methods, but the difference was not statistically significant. At the distal portion, bone mineral density was significantly lower in the study group. The duration of depot MPA use was not related to bone mineral density. Women > or =35 years of age presented with a lower bone mineral density only at the distal portion of the forearm after the use of depot MPA for > or =1 year. However, this decrease was not related to the duration of depot MPA use. It is not possible to conclude that women who use depot MPA are at risk of osteoporosis.
dc.description71
dc.description849-52
dc.languageeng
dc.relationFertility And Sterility
dc.relationFertil. Steril.
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectAdult
dc.subjectBone Density
dc.subjectContraceptive Agents, Female
dc.subjectCross-sectional Studies
dc.subjectFemale
dc.subjectForearm
dc.subjectHumans
dc.subjectLinear Models
dc.subjectMedroxyprogesterone Acetate
dc.subjectMiddle Aged
dc.subjectPremenopause
dc.subjectRadius
dc.subjectRetrospective Studies
dc.subjectTime Factors
dc.subjectTreatment Outcome
dc.subjectUlna
dc.subjectAmericas
dc.subjectBiology
dc.subjectBrazil
dc.subjectComparative Studies
dc.subjectContraception
dc.subjectContraceptive Agents, Female--side Effects
dc.subjectContraceptive Agents, Progestin--side Effects
dc.subjectContraceptive Agents--side Effects
dc.subjectDemographic Factors
dc.subjectDepo-provera--side Effects
dc.subjectDeveloping Countries
dc.subjectFamily Planning
dc.subjectFertility
dc.subjectFertility Measurements
dc.subjectLatin America
dc.subjectLongterm Effects--women
dc.subjectMedroxyprogesterone Acetate--side Effects
dc.subjectOsteoporosis--women
dc.subjectParity
dc.subjectPhysiology
dc.subjectPopulation
dc.subjectPopulation Dynamics
dc.subjectResearch Methodology
dc.subjectResearch Report
dc.subjectRisk Factors--women
dc.subjectSkeletal Effects
dc.subjectSouth America
dc.subjectStudies
dc.subjectTime Factors
dc.subjectWomen
dc.titleForearm Bone Density In Users Of Depo-provera As A Contraceptive Method.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución